Issue # 125 – India’s Digital Healthcare Market $40 Billion Opportunity by 2030, latest report

India’s digital healthcare ecosystem is on a fast track to become a USD 40 billion opportunity by 2027–2030, as per our latest report. 

The report, titled DIGITAL HEALTHCARE IN INDIA: A USD 40 BILLION OPPORTUNITY, offers a deep dive into the market landscape, growth trends, funding patterns, regulatory developments, and strategic imperatives shaping the sector. 

Our report aims to serve as a strategic guide for businesses, investors, and policymakers to unlock the full potential of India’s healthtech revolution. 

Access the Report

Naarica, a leading brand in sanitary hygiene, has partnered with badminton champion Saina Nehwal, who joins as an investor and brand ambassador.

Read the News

In celebration of Women’s Day, we are spotlighting female trailblazers from our global community. Throughout March, we’re sharing the stories of inspiring women from diverse backgrounds who are driving innovation in women’s health and beyond—amplifying their voices and contributions to the industry. 

Meet Dr. Roopan Gill MD MPH FRCSC (ObGyn) Gill, an OB-GYN and Co-founder of Vitala Global Foundation.

A Canadian-trained OBGYN specializing in family planning, Dr. Gill has dedicated her career to advancing contraception and abortion care. As a clinician scientist and assistant professor at the University of Toronto’s Department of Obstetrics and Gynecology, she combines academic expertise with innovation to improve reproductive health.

As the co-founder and CEO of Vitala Global Foundation, a Canadian tech-driven nonprofit, Dr. Gill is committed to using technology to enhance reproductive autonomy worldwide. Her passion for humanitarian work has taken her on field missions with Doctors Without Borders in Nigeria and Yemen, and as the Women’s Health Advisor for MSF France, she has supported sexual and reproductive health initiatives across 30 countries.

Read Her Full Story

• At the HIMSS25 Global Health Conference, AvaSure introduced Vicky, an AI-powered virtual care assistant designed to assist hospitals in managing patient requests and streamlining clinical workflows. 
• The NHS is implementing a new artificial intelligence (AI) tool developed by health tech company Cera, which can predict patients’ risk of falling with 97% accuracy. This innovation aims to prevent as many as 2,000 falls and hospital admissions daily.
• Oracle Health has expanded the availability of its Clinical AI Agent, an advanced AI-powered, multimodal voice, and screen-driven assistant, to support more than 30 medical specialty areas.
• Epic is broadening its portfolio beyond electronic health records (EHR) by developing a healthcare-specific enterprise resource planning (ERP) system. Announced at the Healthcare Information and Management Systems Society (HIMSS) conference, the initiative places Epic in direct competition with industry giants like Oracle and Workday.

• Osivax, a Lyon, France-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating respiratory viruses, closed its Series B financing, raising €10M from new and existing investors.
• Boomerang Ventures has led a $2.6 million seed funding round for Lizzy Care, a health tech company offering an AI-powered platform for at-home dementia and memory care. The investment will help Lizzy Care expand its technology platform that combines predictive analytics, real-time care coordination, and local care management to make high-quality dementia care more accessible.
• Wingwomen Technologies has secured $2 million in investment from a group of private investors to advance the development of its digital vaginal speculum, Nina. The funding announcement comes on the heels of the company winning the FemTech Product of the Year award at the MedTech World Awards in Dubai this past February.
• Flosonics Medical, a Sudbury, Ontario, Canada-based medical device company, received CAD$7.5M in Venture Debt from RBCx.The company intends to use the funds to expand the reach of FloPatch and consolidate its position as a player in life sciences innovation.
• Sofinnova Partners, a leading European venture capital firm specializing in life sciences, has announced it has raised €1.2 billion across its investment strategies over the past year. The Paris-based firm secured more than €1 billion of this amount in the last quarter alone, bringing its total assets under management to over €4 billion.
• BioInnovation Institute (BII) has announced a 4 million DKK (approximately €500,000) investment in Beech Biotech, a Swiss startup developing a groundbreaking treatment for preeclampsia. The funding comes as part of BII’s latest Venture Lab cohort announced last week.
• hema.to, a Munich, Germany-based digital medtech company, raised €3.6M in funding. The round was led by LUMO Labs and followed by Bayern Kapital and investors from their previous round.

• Breastfeeding can promote lower blood pressure among children, a new study says. Longer-term breastfeeding appears to populate a baby’s gut with diverse bacteria that could help lower blood pressure, researchers found. Children who were breastfed for at least six months had lower blood pressure at age 6, researchers report in the Journal of the American Heart Association.
• People put a lot of thought into getting a tattoo – the design they desire, the location they prefer and the message their body art will send to others. Most don’t think about the impact their tattoo might have on their long-term health, but perhaps they should, a new study suggests. Tattoos appear to increase a person’s risk of skin cancer between 33% and 62%, according to a new Danish study in the journal BMC Health.
• Preventive screenings for cancer declined during the pandemic, with lockdowns, social distancing and COVID-19 surges keeping many from needed mammograms and colonoscopies. But breast and colon cancer screening numbers have since rebounded and have even surpassed pre-pandemic screening estimates, a new American Cancer Society study has found.
• The antiviral drug Paxlovid may not offer much protection against COVID-related hospitalizations or deaths for vaccinated older adults after all. Research published recently in JAMA Network Open looked at data from more than 1.6 million adults ages 65 to 74 in Ontario, Canada, during 2022.
• Men with strong, fast-swimming sperm may not only have better fertility but also longer lives, a new study suggests. Researchers tracked more than 78,000 men over 50 years and found that those with higher sperm motility — the ability of sperm to swim — lived nearly three years longer than men with poor sperm movement.
• Over-the-counter drugs like aspirin or ibuprofen might help protect against dementia, a new study suggests.These NSAIDs (non-steroidal anti-inflammatory drugs) might help protect the brain by quelling inflammation that contributes to dementia, researchers reported in the Journal of the American Geriatrics Society.
• Seniors battling insomnia are best off picking up some dumbbells or doing some push-ups, a new evidence review suggests. Resistance exercise, activities that make muscles work against an external force, appears to be the best means of improving sleep in older adults, researchers found.
• Opting for a lumpectomy during breast cancer treatment can protect a woman’s future sex life, a new study suggests. Breast-conserving therapy (BCT) is associated with better sexual well-being, compared to mastectomy followed by breast reconstruction, researchers found.
• Cases of postmenopausal osteoarthritis, and disabilities associated with the condition, have surged globally by more than 130 per cent over the last three decades, data shows.

• Mayo Clinic has unveiled a $1.9 billion expansion plan for its Phoenix medical campus, marking the largest investment in the nonprofit’s history in Arizona. 
• Biocon Biologics and Civica Inc.  not-for-profit generic drug and pharmaceutical company founded in 2018 to address and resolve life-saving drug shortages and affordability, has inked a strategic collaboration agreement to expand access and affordability of insulin aspart in the United States.
• Fortis Healthcare has announced its acquisition of Shrimann Superspecialty Hospital in Jalandhar for INR 462 crore, significantly expanding its footprint in Punjab. 
• SiS: Women’s Health, the platform accelerating innovation in women’s healthcare, has announced the launch of the EMD Serono Corporate Accelerator (ESCA) programme in conjunction with SiS New York 2025.
• Smart ring maker OURA and a global research body are collaborating to gain a greater understanding of  behavioural changes during pregnancy. OURA is collaborating with Scripps Research Digital Trials Center and aims to include 10,000 users in its new study.

• The Gujarat Food and Drug Control Administration (FDCA) will be equipping its drug inspectors with advanced handheld spectrophotometers for onsite drug testing.
• The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest meeting.
• Himachal Pradesh will soon see the establishment of hi-tech testing laboratories across the state, as announced by the State Health Minister, Dhani Ram Shandil, during a recent meeting of the Cabinet subcommittee.

📳 – Casual Reads: 

• Surgery Just Before The Weekend? Bad Idea, Study Says: Folks facing surgery on a Friday may want to consider rescheduling if they can based on findings from a new study. 
• ‘Cycle Syncing‘ Doesn’t Boost Strength Training Results: Social media influencers tout the benefits of “cycle syncing” to boost strength training results among women.
• Bad Meetings Can Leave You With a Productivity ‘Hangover‘: Bad meetings don’t just waste time — they can leave workers with a “meeting hangover,” new research shows.

See you next Friday, friends 👋
Navneet

[Sign up here to never miss on the latest updates.]